Corrigendum to The need for strategic development of safety sciences

Most read articles by the same author(s)

• Lena Smirnova, Helena T. Hogberg, Marcel Leist, Thomas Hartung, Developmental neurotoxicity – Challenges in the 21st century and in vitro opportunities , ALTEX - Alternatives to animal experimentation: Vol. 31 No. 2 (2014)
• Mangala Gunatilake, Francois Busquet, Mohammad A. Akbarsha, Alternatives initiative in Sri Lanka: Pre- and post-conference workshops at the Inaugural Scientific Conference of the Sri Lanka Association for Laboratory Animal Science , ALTEX - Alternatives to animal experimentation: Vol. 31 No. 2 (2014)
• Nina Hasiwa, Mardas Daneshian, Peter Bruegger, Stefan Fennrich, Astrid Hochadel, Sebastian Hoffmann, Felix E. Rivera-Mariani, Christoph Rockel, Stefanie Schindler, Ingo Spreitzer, Sandra Stoppelkamp, Kranthi Vysyaraju, Thomas Hartung, Addendum to Evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test , ALTEX - Alternatives to animal experimentation: Vol. 31 No. 2 (2014)
• Andre Kleensang, Alexandra Maertens, Michael Rosenberg, Suzanne Fitzpatrick, Justin Lamb, Scott Auerbach, Richard Brennan, Kevin M. Crofton, Ben Gordon, Albert J. Jr. Fornace, Kevin Gaido, David Gerhold, Robin Haw, Adriano Henney, Avi Ma’ayan, Mary McBride, Stefano Monti, Michael F. Ochs, Akhilesh Pandey, Roded Sharan, Rob Stierum, Stuart Tugendreich, Catherine Willett, Clemens Wittwehr, Jianguo Xia, Geoffrey W. Patton, Kirk Arvidson, Mounir Bouhifd, Helena T. Hogberg, Thomas Luechtefeld, Lena Smirnova, Liang Zhao, Yeyejide Adeleye, Minoru Kanehisa, Paul Carmichael, Melvin E. Andersen, Thomas Hartung, Pathways of Toxicity , ALTEX - Alternatives to animal experimentation: Vol. 31 No. 1 (2014)
• Daland R. Juberg, Susan J. Borghoff, Richard A. Becker, Warren Casey, Thomas Hartung, Michael P. Holsapple, M. Sue Marty, Ellen M. Mihaich, Glen Van Der Kraak, Michael G. Wade, Catherine E. Willett, Melvin E. Andersen, Christopher J. Borgert, Katherine K. Coady, Michael L. Dourson, John R. Fowle III, L. Earl Gray, James C. Lamb, Lisa S. Ortego, Thaddeus T. Schug, Colleen M. Toole, Leah M. Zorrilla, Oliver L. Kroner, Jacqueline Patterson, Lori A. Rinckel, Brett R. Jones, Lessons learned, challenges, and opportunities: The U.S. Endocrine Disruptor Screening Program , ALTEX - Alternatives to animal experimentation: Vol. 31 No. 1 (2014)
• Ambuja S. Bale, Elaina Kenyon, Thomas J. Flynn, John C. Lipscomb, Donna L. Mendrick, Thomas Hartung, Geoffrey W. Patton, Correlating in vitro data to in vivo findings for risk assessment , ALTEX - Alternatives to animal experimentation: Vol. 31 No. 1 (2014)
• Thomas Hartung, Emanuela Corsini, Immunotoxicology: Challenges in the 21st century and in vitro opportunities , ALTEX - Alternatives to animal experimentation: Vol. 30 No. 4 (2013)
• Mardas Daneshian, Luis M. Botana, Marie-Yasmine Dechraoui Bottein, Gemma Buckland, Mònica Campàs, Ngaire Dennison, Robert W. Dickey, Jorge Diogène, Valérie Fessard, Thomas Hartung, Andrew Humpage, Marcel Leist, Jordi Molgó, Michael A. Quilliam, Costanza Rovida, Benjamin A. Suarez-Isla, Aurelia Tubaro, Kristina Wagner, Otmar Zoller, Daniel Dietrich, A roadmap for hazard monitoring and risk assessment of marine biotoxins on the basis of chemical and biological test systems , ALTEX - Alternatives to animal experimentation: Vol. 30 No. 4 (2013)
• Thomas Hartung, Look back in anger – what clinical studies tell us about preclinical work , ALTEX - Alternatives to animal experimentation: Vol. 30 No. 3 (2013)
• Louise Parks Saldutti, Bruce K. Beyer, William Breslin, Terry R. Brown, Robert E. Chapin, Brian Enright, Elaine Faustman, Paul M. D. Foster, Thomas Hartung, William Kelce, James H. Kim, Elizabeth G. Loboa, Aldert H. Piersma, David Seyler, Katie J. Turner, Hanry Yu, Xiaozhong Yu, Jennifer C. Sasaki, In vitro testicular toxicity models: Opportunities for advancement via biomedical engineering techniques , ALTEX - Alternatives to animal experimentation: Vol. 30 No. 3 (2013)